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Background
Cyclic GMP (cGMP) is a major mediator of relaxation in
the vascular system. cGMP is produced by the enzyme
soluble Guanylyl Cyclase (sGC) in response to nitric
oxide (NO) released from neighbouring endothelial cells.
cGMP activates Protein Kinase G (PKG), which in turn
mediates vascular relaxation through phosophorylation
of various targets. One of the major substrates of PKG is
the VAsodilator-Stimulated Phosphoprotein (VASP). The
role of VASP in vascular smooth muscle relaxation is
currently unknown. However, recent studies show that
VASP-deficient brown adipocytes have an increased
* Correspondence: shil@uni-bonn.de
1Institute of Pharmacology and Toxicology, University of Bonn, Bonn, NRW,
53105, Germany
Full list of author information is available at the end of the article
Figure 1 Expression of PKGI and the ß1-subunit of sGC in VASP-/- and wild-type murine aortas as determined by western blotting N=3.
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activity of the small GTPase Rac1 and elevated levels of
sGC [1]. These data suggest a regulatory role for VASP
in cGMP-mediated processes.
Results
Preliminary data acquired from the analysis of VASP-defi-
cient (VASP-/-) mice provide evidence for the importance
of VASP in the cGMP mediated relaxation pathway:
VASP-/- aortas show higher levels of PKG and sGC com-
pared to wild type (see Figure 1), and increased sensitivity
to NO-induced relaxation. Additionally, cultured vascular
smooth muscle cells (VSMCs) transduced with a constitu-
tively active Rac1 mutant (RacL61) show elevated sGC and
PKG expression as well as increased PKG activity.
Cultured VSMCs from VASP-/- aortas also demonstrate
decreased proliferation rates compared to wild-type cells
in preliminary experiments.
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